MedTrace Logo

HKT-500 in Adult Patients With Ankle Sprain

NCT00680784 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2015-06-04

No results posted yet for this study

Summary

The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.

Conditions

  • Ankle Sprain

Interventions

DRUG

HKT-500 Ketoprofen Topical Patch

HKT-500 Ketoprofen Topical Patch

OTHER

Placebo Patch

Placebo Patch

Sponsors & Collaborators

  • Hisamitsu Pharmaceutical Co., Inc.

    lead INDUSTRY

Principal Investigators

  • Kenichi Furuta · Hisamitsu Pharmaceutical Co., Inc.

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00680784 on ClinicalTrials.gov